Related Experiment Videos

Chronic granulomatous disease: six new cases

M A Martín Mateos1, M Alvaro, M T Giner

  • 1Immunoallergy Section, Pediatrics Unit, Hospital Clínico-Hospital San Juan de Dios, University of Barcelona.

Insights

Six new cases of chronic granulomatous disease (CGD), a primary immunodeficiency, were diagnosed. Early-onset, severe bacterial and fungal infections were common, with diagnosis confirmed by NBT and chemiluminescence tests.

Area of Science:

  • Immunology
  • Pediatrics
  • Genetics

Background:

  • Chronic granulomatous disease (CGD) is a primary immunodeficiency affecting phagocyte function.
  • Early diagnosis and management are crucial for improving patient outcomes.
  • Understanding the genetic basis and clinical spectrum is vital for effective treatment.

Observation:

  • Six new CGD cases were identified, representing 1.1% of primary immunodeficiencies.
  • Four cases were male, two female, with X-linked and autosomal recessive inheritance patterns observed.
  • Clinical manifestations, including severe bacterial and fungal infections, appeared before age two, earlier and more severely in males.

Findings:

  • Common infections included liver, lung, and skin abscesses, lymphadenitis, and mastoiditis; osteomyelitis was absent.
  • Isolated pathogens comprised various bacteria (Staphylococcus, Salmonella, Serratia, Pseudomonas, Enterococcus) and fungi (Candida, Aspergillus, Trichopyton).
  • Diagnostic indicators included leukocytosis, elevated acute phase reactants (PCR, VSG), hypergammaglobulinemia, and high LB/LT4 levels, confirmed by NBT and chemiluminescence tests.

Implications:

  • This study highlights the prevalence and diverse clinical presentations of CGD in pediatric patients.
  • Accurate diagnosis through NBT and chemiluminescence tests is essential for timely intervention.
  • Further research into genetic factors and treatment strategies can improve the management of CGD.

Related Concept Videos